Linnea Thorlacius
15PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jul 13, 2025
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.Vivian Y Shi, John R Ingram, Hadar Lev-Tov
|Apr 02, 2025
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.Joslyn S Kirby, Linnea Thorlacius, Jérémy Lambert
|Nov 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.Hannah E Wainman, Nisha S Chandran, John W Frew
|Mar 27, 2021
How to diagnose and measure primary hyperhidrosis: a systematic review of the literature.Mattias A S Henning, Linnea Thorlacius, Kristina S Ibler
|Oct 22, 2020
Sub-classification of Hidradenitis suppurativa: a cross-sectional study.Linnea Thorlacius, Peter T Riis, Emil Knudsen List
Pageof 3
Frequent Collaborators
8 joint publications
John R Ingram
5 joint publications
Peter Theut Riis
5 joint publications
Amit Garg
5 joint publications
Gregor B Jemec
3 joint publications
Jacek Cezary Szepietowski
3 joint publications
Steven Daveluy
2 joint publications
Stine Thestrup Hansen
2 joint publications
Barbara Horvath
2 joint publications
Christopher Sayed
2 joint publications
Brian Kirby
